Much progress has been made in understanding the mechanism of BIRC2 and BIRC3 in multiple cancers, including liver cancer, chronic lymphocytic leukaemia, breast cancer and ovarian cancer.10 Here, BIRC3 is linked to ovarian carcinoma.